NO306597B1 - Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament - Google Patents

Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament

Info

Publication number
NO306597B1
NO306597B1 NO942695A NO942695A NO306597B1 NO 306597 B1 NO306597 B1 NO 306597B1 NO 942695 A NO942695 A NO 942695A NO 942695 A NO942695 A NO 942695A NO 306597 B1 NO306597 B1 NO 306597B1
Authority
NO
Norway
Prior art keywords
preparation
loweralkyl
pyridinyl
indole
amines
Prior art date
Application number
NO942695A
Other languages
English (en)
Other versions
NO942695L (no
NO942695D0 (no
Inventor
Sathapana Kongsamut
Craig Paul Smith
Ann Theresa Woods
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO942695D0 publication Critical patent/NO942695D0/no
Publication of NO942695L publication Critical patent/NO942695L/no
Publication of NO306597B1 publication Critical patent/NO306597B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO942695A 1993-07-19 1994-07-18 Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament NO306597B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/092,848 US5356910A (en) 1993-07-19 1993-07-19 Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Publications (3)

Publication Number Publication Date
NO942695D0 NO942695D0 (no) 1994-07-18
NO942695L NO942695L (no) 1995-01-20
NO306597B1 true NO306597B1 (no) 1999-11-29

Family

ID=22235450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942695A NO306597B1 (no) 1993-07-19 1994-07-18 Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament

Country Status (21)

Country Link
US (1) US5356910A (no)
EP (1) EP0635269B1 (no)
JP (1) JP2807633B2 (no)
KR (1) KR100325276B1 (no)
AT (1) ATE186215T1 (no)
AU (1) AU673747B2 (no)
CA (1) CA2128312C (no)
CZ (1) CZ288593B6 (no)
DE (1) DE69421457T2 (no)
DK (1) DK0635269T3 (no)
EG (1) EG20716A (no)
ES (1) ES2138017T3 (no)
GR (1) GR3032292T3 (no)
HU (1) HU217063B (no)
MX (1) MX9405209A (no)
NO (1) NO306597B1 (no)
NZ (1) NZ264015A (no)
PL (1) PL304335A1 (no)
RU (1) RU2164795C2 (no)
TW (1) TW349864B (no)
ZA (1) ZA945236B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
CN1184969C (zh) * 1995-07-27 2005-01-19 阿温蒂斯药物公司 未取代和取代的n－(吡咯－1－基)吡啶胺作为抗惊厥药的用途
JP4608723B2 (ja) * 1999-03-10 2011-01-12 東ソー株式会社 置換インドール誘導体の製造方法
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2892022B1 (fr) * 2005-10-19 2008-01-04 Urogene Sa Traitement des symptomes de l'irritation de la vessie
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
ATE115143T1 (de) 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5177088A (en) 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5185350A (en) 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
DE69421457D1 (de) 1999-12-09
KR950002761A (ko) 1995-02-16
ES2138017T3 (es) 2000-01-01
ATE186215T1 (de) 1999-11-15
US5356910A (en) 1994-10-18
NZ264015A (en) 1997-07-27
DE69421457T2 (de) 2000-05-04
EP0635269B1 (en) 1999-11-03
AU673747B2 (en) 1996-11-21
HU217063B (hu) 1999-11-29
GR3032292T3 (en) 2000-04-27
HUT69709A (en) 1995-09-28
KR100325276B1 (ko) 2002-09-25
EG20716A (en) 1999-12-29
PL304335A1 (en) 1995-01-23
AU6753194A (en) 1995-01-27
NO942695L (no) 1995-01-20
HU9402124D0 (en) 1994-09-28
MX9405209A (es) 1995-01-31
RU94026084A (ru) 1996-08-27
CZ173094A3 (en) 1995-02-15
CA2128312C (en) 2004-09-28
JP2807633B2 (ja) 1998-10-08
NO942695D0 (no) 1994-07-18
ZA945236B (en) 1995-02-28
CZ288593B6 (cs) 2001-07-11
TW349864B (en) 1999-01-11
CA2128312A1 (en) 1995-01-20
RU2164795C2 (ru) 2001-04-10
EP0635269A1 (en) 1995-01-25
JPH0753376A (ja) 1995-02-28
DK0635269T3 (da) 2000-04-25

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
NO2005019I2 (no) Metylaminolevulinat, eventuelt i form av et salt, fortrinnsvis metylaminolevulinat-hydroklorid
AP9701041A0 (en) Pyridylpyrrole compounds.
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
NO306597B1 (no) Anvendelse av N-(pyridinyl)-1H-indol-1-aminer for fremstilling av et medikament
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DK557189D0 (da) 1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
MX9709396A (es) Derivados de fenoxipiperazina para el tratamiento de transtornos del sistema dopamina.

Legal Events

Date Code Title Description
MK1K Patent expired